HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer-Reference-Cited by-同舟云学术

HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer

Published:2014-07-20 Issue:3 Volume:18 Page:476-484
ISSN:1436-3291
Container-title:Gastric Cancer
language:en
Short-container-title:Gastric Cancer

Author:

Van Cutsem Eric,Bang Yung-Jue,Feng-yi Feng,Xu Jian M.,Lee Keun-Wook,Jiao Shun-Chang,Chong Jorge León,López-Sanchez Roberto I.,Price Timothy,Gladkov Oleg,Stoss Oliver,Hill Julie,Ng Vivian,Lehle Michaela,Thomas Marlene,Kiermaier Astrid,Rüschoff Josef

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Gastroenterology,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s10120-014-0402-y.pdf

Reference29 articles.

1. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science. 1989;244:707–12.

2. Gravalos C, Jimeno A. HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target. Ann Oncol. 2008;19:1523–9.

3. Vogel CL, Cobleigh MA, Tripathy D, Gutheil JC, Harris LN, Fehrenbacher L, et al. Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer. J Clin Oncol. 2002;20:719–26.

4. Hofmann M, Stoss O, Shi D, Büttner R, van de Vijver M, Kim W, et al. Assessment of a HER2 scoring system for gastric cancer: results from a validation study. Histopathology. 2008;52:797–805.

5. Park DI, Yun JW, Park JH, Oh SJ, Kim HJ, Cho YK, et al. HER-2/neu amplification is an independent prognostic factor in gastric cancer. Dig Dis Sci. 2006;51:1371–9.

Cited by 453 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling the future: Innovative design strategies and emerging challenges in HER2-targeted tyrosine kinase inhibitors for cancer therapy;European Journal of Medicinal Chemistry;2024-10

2. HER2-low gastric cancer: is the subgroup targetable?;ESMO Open;2024-09

3. HER-2 directed therapies across gastrointestinal tract cancers – A new frontier;Cancer Treatment Reviews;2024-09

4. The correlation between the CT texture features of gastric cancer in arterial phase and the expression of HER-2 and Ki-67;Journal of Radiation Research and Applied Sciences;2024-09

5. Identification of key genes and pathways involved in T-DM1-resistance in OE-19 esophageal cancer cells through bioinformatics analysis;Heliyon;2024-09